EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve‐in‐Valve Registry

Hilal Khan iD, Mohamed Ali, Abdalazeem Ibrahem iD, Karim Ratib iD, Nur Ilia Mohd Zaki, Freidoon Keshavarzi iD, Alok Shah iD, Hesham Abdelaziz iD, Ayush Khurana, Alexander Chase, Diana A Gorog iD, Rajiv Das und 3 weitere

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70811 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Hilal Khan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Department, Freeman Hospital, Newcastle Upon Tyne, UK. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Bioprosthesis, Transcatheter Aortic Valve Replacement, Aortic Valve. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The prevalence of bioprosthetic aortic valve failure is increasing due to the broader use of bioprosthetic valves, both surgical and transcatheter, and an ageing population. Registry data indicate a higher risk of coronary obstruction and elevated gradients following valve‐in‐valve transcatheter aortic valve implantation (TAVI). We report outcomes of the Allegra transcatheter heart valve system in valve‐in‐valve TAVI.

Methods

In this retrospective multicentre cohort study, all patients undergoing valve‐in‐valve TAVI with the Allegra system between 2019 and 2025 at five UK centers were included. The combined primary outcomes were technical success, device success, and early safety at 30 days, as per the VARC‐3 (Valve Academic Research Consortium‐3) criteria. A key secondary outcome was all‐cause mortality at the longest documented follow‐up.

Results

A total of 106 patients underwent valve‐in‐valve TAVI. The mean age was 79 ± 6 years, with 57.5% being female. Almost half of the patients had an index valve ≤ 21 mm, with an STS (Society of Thoracic Surgery) score of 7.1% (5.1–12.0). The post‐implant aortic valve mean pressure gradient was 12 ± 6 mmHg, and the mean valve area was 1.7 ± 0.5 cm 2 . The combined primary outcomes were technical success of 86.8% (CI 80.3%–93.2%), device success of 75.5% (CI 67.3%–83.7%), and early safety of 86.8% (CI 80.3%–93.2%). All‐cause mortality at 30 days was 0%. All‐cause mortality occurred in 6.6% at a median follow‐up of 15 months.

Conclusions

The Allegra TAVI system demonstrates promising technical and device success rates, with early safety and good post‐implant haemodynamic performance in high‐risk patients undergoing valve‐in‐valve TAVI. Larger randomized trials are needed to confirm these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisBioprosthesisTranscatheter Aortic Valve ReplacementAortic ValveAortic Valve StenosisProsthesis FailureHumansFemaleRegistriesRetrospective StudiesProsthesis DesignMaleAged, 80 and overTime FactorsRisk FactorsAgedHemodynamicsUnited KingdomTreatment OutcomeRisk Assessment

Stichwörter der Autor:innen

AllegraTAVIaortic stenosistranscatheter aortic valve implantationvalve‐in‐valve

Autor:innen und Institutionen

  • Cardiothoracic Department, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, UK.
  • Cardiac Department, Manchester Royal Infirmary, Manchester, UK.
  • Lancashire Cardiac Centre, Blackpool Victoria Hospital, Blackpool, UK.
  • Swansea Bay University Health Board, Swansea, UK.
  • National Heart and Lung Institute, Imperial College, London, UK.

ORCID-Profile: Hilal Khan, Abdalazeem Ibrahem, Karim Ratib, Freidoon Keshavarzi, Alok Shah, Hesham Abdelaziz, Diana A Gorog, Azfar Zaman, Mohamed Farag

Zitieren

APA

Khan, H., Ali, M., Ibrahem, A., Ratib, K., Zaki, N. I. M., Keshavarzi, F., Shah, A., Abdelaziz, H., Khurana, A., Chase, A., Gorog, D. A., Das, R., Zaman, A., AlKhalil, M., & Farag, M. (2026). Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve‐in‐Valve Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70811

Vancouver

Khan H, Ali M, Ibrahem A, Ratib K, Zaki NIM, Keshavarzi F, et al. Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve‐in‐Valve Registry. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70811

BibTeX
@article{Khan2026,
  author = {Khan, Hilal and Ali, Mohamed and Ibrahem, Abdalazeem and Ratib, Karim and Zaki, Nur Ilia Mohd and Keshavarzi, Freidoon and Shah, Alok and Abdelaziz, Hesham and Khurana, Ayush and Chase, Alexander and Gorog, Diana A and Das, Rajiv and Zaman, Azfar and AlKhalil, Mohammad and Farag, Mohamed},
  title = {Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve‐in‐Valve Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70811}
}
Kostenlos starten →